Need Help?

Potent neutralizing antibodies against SARS-CoV-2

The COVID-19 pandemic urgently needs therapeutic and prophylactic interventions. Here we report the rapid identification of SARS-CoV-2 neutralizing antibodies by high-throughput single-cell RNA and VDJ sequencing of antigen-enriched B cells from 60 convalescent patients.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001006130 Illumina HiSeq 2500 1
Publications Citations
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.
Cell 182: 2020 73-84.e16
792
A review of COVID-19 biomarkers and drug targets: resources and tools.
Brief Bioinform 22: 2021 701-713
9
The COVID-19 Data Portal: accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing.
Nucleic Acids Res 49: 2021 W619-W623
30